INS and Insulin resistance: TRIB3 disrupts insulin signaling by binding directly to AKT and inhibits the insulin-stimulated AKT phosphorylation of Thr308 and Ser473; TRIB3 also contributes to insulin resistance in individuals who are susceptible to type II diabetes17.